Home>
US Stocks>
Biomarin Pharmaceutical

Biomarin Pharmaceutical share price today

(BMRN)

Biomarin Pharmaceutical share price is $66.63 & ₹5,674.14 as on 25 Dec 2024, 2.30 'hrs' IST

$66.63

▲

0.36

(0.54%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Biomarin Pharmaceutical share price in Dollar and Rupees. Guide to invest in Biomarin Pharmaceutical from India. Also see the sentimental analysis on Indian investors investing in Biomarin Pharmaceutical. Get details on the Indian mutual funds that are investing in Biomarin Pharmaceutical. Get Analyst recommendations and forecasts along with all the Biomarin Pharmaceutical's financials.

Biomarin Pharmaceutical share price movements

Today's Low: $65.28
Today's High: $67.07
$66.63
2.03%
Downside
Day's Volatility :2.67%
Upside
0.66%
52 Weeks Low: $61.15
52 Weeks High: $99.25
$66.63
8.22%
Downside
52 Weeks Volatility :38.39%
Upside
32.87%

Biomarin Pharmaceutical Returns

Period	Biomarin Pharmaceutical Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.98%	-10.0%	0.0%
6 Months	-22.26%	-5.7%	0.0%
1 Year	-31.3%	2.8%	0.0%
3 Years	-26.93%	-0.4%	-21.1%

Biomarin Pharmaceutical Key Statistics

in dollars & INR

Previous Close	$66.27
Open	$65.96
Today's High	$67.07
Today's Low	$65.28
Market Capitalization	$12.5B
Today's Volume	$864.6K
52 Week High	$99.25
52 Week Low	$61.15
Revenue TTM	$2.8B
EBITDA	$426.1M
Earnings Per Share (EPS)	$1.66
PE Ratio	39.55
Profit Margin	11.71%
Quarterly Earnings Growth YOY	1.61%
Return On Equity TTM	6.25%

How to invest in Biomarin Pharmaceutical from India?

It is very easy for Indian residents to invest directly in Biomarin Pharmaceutical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biomarin Pharmaceutical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biomarin Pharmaceutical or BMRN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biomarin Pharmaceutical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biomarin Pharmaceutical shares which would translate to 0.013 fractional shares of Biomarin Pharmaceutical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biomarin Pharmaceutical, in just a few clicks!

Returns in Biomarin Pharmaceutical for Indian investors in Rupees

Investment Value

₹1,00,000

Biomarin Pharmaceutical investment value today

Current value as on today

₹71,474

Returns

₹28,526

(-28.53%)

Returns from Biomarin Pharmaceutical Stock

₹30,925 (-30.92%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Biomarin Pharmaceutical

-33%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Biomarin Pharmaceutical on INDmoney from India has reduced in the last 30 days as on Dec 25, 2024. -33% less investors are searching Biomarin Pharmaceutical in the last 30 days versus the previous period.

Global Institutional Holdings in Biomarin Pharmaceutical

BlackRock Inc
11.93%
Vanguard Group Inc
10.12%
PRIMECAP Management Company
9.90%
Dodge & Cox
7.29%
Capital Research Global Investors
5.51%
Viking Global Investors LP
5.12%

Analyst Recommendation on Biomarin Pharmaceutical

Buy

74%Buy

25%Hold

0%Sell

Based on 35 Wall street analysts offering stock ratings for Biomarin Pharmaceutical(by analysts ranked 0 to 5 stars)

Based on 35 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biomarin Pharmaceutical

What analysts predicted

Upside of 47.2%

Current:

$66.63

Target:

$98.08

Insights on Biomarin Pharmaceutical

Price Movement
In the last 1 month, BMRN stock has moved up by 3.1%
Increasing Revenue
Revenue is up for the last 5 quarters, 585.96M → 745.74M (in $), with an average increase of 5.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 107.17M → 106.08M (in $), with an average decrease of 1.0% per quarter
BMRN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.8% return, outperforming this stock by 57.9%
BMRN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 24.7% return, outperforming this stock by 52.0%
Price to Sales
ForBMRN every $1 of sales, investors are willing to pay $4.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Biomarin Pharmaceutical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.5B	↑ 13.52%
Net Income	$-77.2M	↓ 34.03%
Net Profit Margin	-5.18%	↑ 3.73%

	FY19	Y/Y Change
Revenue	$1.7B	↑ 14.27%
Net Income	$-23.8M	↓ 69.11%
Net Profit Margin	-1.4%	↑ 3.78%

	FY20	Y/Y Change
Revenue	$1.9B	↑ 9.18%
Net Income	$854.0M	↓ 3681.13%
Net Profit Margin	45.9%	↑ 47.3%

	FY21	Y/Y Change
Revenue	$1.8B	↓ 0.76%
Net Income	$-64.1M	↓ 107.5%
Net Profit Margin	-3.47%	↓ 49.37%

	FY22	Y/Y Change
Revenue	$2.1B	↑ 13.53%
Net Income	$141.6M	↓ 320.91%
Net Profit Margin	6.75%	↑ 10.22%

	FY23	Y/Y Change
Revenue	$2.4B	↑ 15.42%
Net Income	$167.6M	↑ 18.43%
Net Profit Margin	6.93%	↑ 0.18%

	Q2 FY23	Q/Q Change
Revenue	$594.6M	↑ 0.28%
Net Income	$56.0M	↑ 10.2%
Net Profit Margin	9.42%	↑ 0.84%

	Q3 FY23	Q/Q Change
Revenue	$586.0M	↓ 1.45%
Net Income	$40.4M	↓ 27.95%
Net Profit Margin	6.89%	↓ 2.53%

	Q4 FY23	Q/Q Change
Revenue	$646.2M	↑ 10.28%
Net Income	$20.4M	↓ 49.54%
Net Profit Margin	3.15%	↓ 3.74%

	Q1 FY24	Q/Q Change
Revenue	$648.8M	↑ 0.41%
Net Income	$88.7M	↑ 335.15%
Net Profit Margin	13.66%	↑ 10.51%

	Q2 FY24	Q/Q Change
Revenue	$708.7M	↑ 9.22%
Net Income	$107.2M	↑ 20.88%
Net Profit Margin	15.12%	↑ 1.46%

	Q3 FY24	Q/Q Change
Revenue	$745.7M	↑ 5.23%
Net Income	$106.1M	↓ 1.02%
Net Profit Margin	14.22%	↓ 0.9%

	FY18	Y/Y Change
Profit	$1.2B	↑ 9.71%

	FY19	Y/Y Change
Profit	$1.3B	↑ 14.34%

	FY20	Y/Y Change
Profit	$1.3B	↓ 0.62%

	FY21	Y/Y Change
Profit	$1.4B	↑ 2.96%

	FY22	Y/Y Change
Profit	$1.6B	↑ 17.2%

	FY23	Y/Y Change
Profit	$1.8B	↑ 14.25%

	Q2 FY23	Q/Q Change
Profit	$450.9M	↑ 0.05%

	Q3 FY23	Q/Q Change
Profit	$445.5M	↓ 1.19%

	Q4 FY23	Q/Q Change
Profit	$510.7M	↑ 14.63%

	Q1 FY24	Q/Q Change
Profit	$509.4M	↓ 0.27%

	Q2 FY24	Q/Q Change
Profit	$563.9M	↑ 10.71%

	Q3 FY24	Q/Q Change
Profit	$557.3M	↓ 1.17%

	FY18	Y/Y Change
Operating Cash Flow	$20.2M	↓ 330.76%
Investing Cash Flow	$264.4M	↓ 186.54%
Financing Cash Flow	$-388.0M	↓ 176.51%

	FY19	Y/Y Change
Operating Cash Flow	$48.3M	↑ 138.83%
Investing Cash Flow	$-31.0M	↓ 111.74%
Financing Cash Flow	$-74.7M	↓ 80.75%

	FY20	Y/Y Change
Operating Cash Flow	$85.4M	↑ 76.88%
Investing Cash Flow	$-53.6M	↑ 72.83%
Financing Cash Flow	$181.1M	↓ 342.54%

	FY21	Y/Y Change
Operating Cash Flow	$304.5M	↑ 256.75%
Investing Cash Flow	$-366.3M	↑ 583.15%
Financing Cash Flow	$-48.0K	↓ 100.03%

	FY22	Y/Y Change
Operating Cash Flow	$175.9M	↓ 42.24%
Investing Cash Flow	$-20.0M	↓ 94.53%
Financing Cash Flow	$-18.7M	↑ 38754.17%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$70.1M	↓ 194.77%
Investing Cash Flow	$29.5M	↓ 198.39%
Financing Cash Flow	$12.0M	↓ 129.36%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$135.6M	↑ 93.61%
Investing Cash Flow	$-45.8M	↓ 255.09%
Financing Cash Flow	$-788.0K	↓ 106.59%

Biomarin Pharmaceutical Technicals Summary

Sell

Neutral

Buy

Biomarin Pharmaceutical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Biomarin Pharmaceutical Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biomarin Pharmaceutical Inc.	1.81%	-22.26%	-31.3%	-26.93%	-22.57%
Regeneron Pharmaceuticals, Inc.	-4.59%	-33.11%	-15.82%	12.66%	91.56%
Biontech Se	-6.0%	37.55%	8.38%	-55.46%	248.4%
Alnylam Pharmaceuticals, Inc.	-3.47%	-1.19%	26.71%	50.37%	106.11%
Vertex Pharmaceuticals Incorporated	-12.22%	-14.5%	-0.59%	82.27%	83.4%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biomarin Pharmaceutical Inc.	39.55	39.55	0.41	3.27	0.06	0.03	NA	28.41
Regeneron Pharmaceuticals, Inc.	17.36	17.36	1.04	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.04	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biomarin Pharmaceutical Inc.	Buy	$12.5B	-22.57%	39.55	11.71%
Regeneron Pharmaceuticals, Inc.	Buy	$77.1B	91.56%	17.36	33.61%
Biontech Se	Buy	$27.1B	248.4%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.7B	106.11%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.3B	83.4%	32.84	-4.51%

About Biomarin Pharmaceutical

biomarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. we remain steadfast to our original mission—to bring new treatments to market that will make a big impact on small patient populations. these patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. these conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored. time is critical to patients with rare diseases, and we strive to quickly develop important therapies for them. the efficiency and speed of our research, development, manufacturing, and commercial efforts is at the heart of our ability to urgently deliver therapies. our track record of developing and commercializing new treatment

Organization	Biomarin Pharmaceutical
Employees	3401
CEO	Mr. Alexander Hardy
Industry	Health Technology

Management People of Biomarin Pharmaceutical

Name	Title
Mr. Alexander Hardy	President, CEO & Director
Mr. Brian R. Mueller CPA	CFO & Executive VP
Dr. C. Greg Guyer Ph.D.	Executive VP & CTO
Dr. Henry J. Fuchs M.D., Ph.D.	Advisor
Ms. Erin Burkhart	Group VP & Chief Accounting Officer
Dr. Kevin Eggan Ph.D.	Chief Scientific Officer & Senior VP of Research and Early Development
Ms. Traci McCarty	Group Vice President of Investor Relations
Mr. George Eric Davis J.D.	Executive VP, Chief Legal Officer, General Counsel & Secretary
Ms. Humaira Serajuddin	Senior VP & Chief Marketing Officer
Ms. Amy Wireman	Executive VP & Chief People Officer

Important FAQs about investing in Biomarin Pharmaceutical from India :

What is Biomarin Pharmaceutical share price today?

Biomarin Pharmaceutical share price today stands at $66.63, Open: $65.96 ; Previous Close: $66.27 ; High: $67.07 ; Low: $65.28 ; 52 Week High: $99.25 ; 52 Week Low: $61.15. The stock opens at $65.96, after a previous close of $66.27. The stock reached a daily high of $67.07 and a low of $65.28, with a 52-week high of $99.25 and a 52-week low of $61.15.

Can Indians buy Biomarin Pharmaceutical shares?

Yes, Indians can invest in the Biomarin Pharmaceutical (BMRN) from India.

With INDmoney, you can buy Biomarin Pharmaceutical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biomarin Pharmaceutical at zero transaction cost.

How can I buy Biomarin Pharmaceutical shares from India?

It is very easy to buy Biomarin Pharmaceutical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biomarin Pharmaceutical be purchased?

Yes, you can buy fractional shares of Biomarin Pharmaceutical with INDmoney app.

What are the documents required to start investing in Biomarin Pharmaceutical stocks?

To start investing in Biomarin Pharmaceutical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.